ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982

NCI Sets Rules For Omics Studies

October 18, 2013